RxDoctor Payments Data

David Appel, MD

Interventional Cardiology · Spokane, WANPI 1528285509

Payments from drug & device makers

$2,377in general payments, 2019–2025

Across 33 payments — averaging $72.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$1K
  • Medtronic$775
  • Abiomed$238
  • Shockwave Medical, Inc$21

What the payments were for

  • Travel & lodging$1,00342%
  • Food & beverage$1,37458%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences20$1,342
Medtronic(2 entities)10$775
Abiomed2$238
Shockwave Medical, Inc1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,377 in reported general payments places this provider in the 35th percentile of 125 interventional cardiology providers in Washington.

See all interventional cardiology providers in Washington

Medicare billing

Part B allowed, 2024
$168,738
Medicare patients
1,946
Services billed
3,305

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban147$169,330
Repatha SureclickEvolocumab44$50,756
XareltoRivaroxaban33$37,661
JardianceEmpagliflozin17$15,809
EntrestoSacubitril/Valsartan14$13,466
Praluent PenAlirocumab11$6,081
Ezetimibe140$5,467
Atorvastatin Calcium275$3,971
Metoprolol Succinate270$3,759
ClopidogrelClopidogrel Bisulfate155$3,727
Rosuvastatin Calcium141$2,788
Prasugrel Hcl28$2,213
Amlodipine Besylate188$1,916
Ranolazine ErRanolazine22$1,653
Losartan Potassium116$1,533

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Spokane

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →